Gene Editing in Agriculture Reaches a Turning Point Amid Legal Battles

Gene editing in plants has moved from lab experiments to real-world applications. Experts now see it as a transformative force in agriculture. Meghan Poon, a partner at law firm Morrison and Foerster, confirms that the technology has reached a turning point in plant science. Over the past decade, powerful gene editing tools like CRISPR-Cas9 have entered the mainstream. This technology allows precise changes to plant DNA, offering faster and more targeted improvements than older methods. In the U.S., gene-edited plants face fewer regulations than transgenic ones because they closely resemble naturally occurring varieties.

European regulators, however, treat gene editing the same as genetic modification. This stricter stance could shift if new rules are introduced. Meanwhile, researchers and startups—from St. Louis to global hubs—are racing to develop and apply these tools.

Intellectual property (IP) protection has become a critical concern. Companies must secure patents early to avoid losing rights to prior art. Two main areas require attention: the gene editing systems themselves and the resulting gene-edited plants. A major risk is accidentally using patented technology, which could lead to costly infringement disputes. The ongoing legal battle between the Broad Institute and the University of California over CRISPR-Cas9 patents highlights how high the stakes are for innovators. The rise of gene editing in agriculture brings both opportunities and legal challenges. Companies must navigate IP laws carefully to protect their work. How regulators adapt—especially in Europe—will shape the future of this fast-moving field.